Target Price | €66.30 |
Price | €59.70 |
Potential |
11.06%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Abivax SA 2026 .
The average Abivax SA target price is €66.30.
This is
11.06%
register free of charge
€92.40
54.77%
register free of charge
€27.27
54.32%
register free of charge
|
|
A rating was issued by 13 analysts: 12 Analysts recommend Abivax SA to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Abivax SA stock has an average upside potential 2026 of
11.06%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | -2.80 | -2.78 |
18.37% | 0.71% | |
P/E | negative | |
EV/Sales | 1,019.77 |
7 Analysts have issued a Abivax SA forecast for earnings per share. The average Abivax SA EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
LIFESCI CAPITAL |
Locked
➜
Locked
|
Locked | Jul 05 2025 |
ODDO BHF |
Locked
➜
Locked
|
Locked | Jun 08 2025 |
BTIG |
Locked
➜
Locked
|
Locked | May 13 2025 |
STIFEL, FORMERLY BRYAN GARNIER |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
LIFESCI CAPITAL |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
ODDO BHF |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
BRYAN GARNIER |
Locked
➜
Locked
|
Locked | Mar 23 2025 |
Analyst Rating | Date |
---|---|
Locked
LIFESCI CAPITAL:
Locked
➜
Locked
|
Jul 05 2025 |
Locked
ODDO BHF:
Locked
➜
Locked
|
Jun 08 2025 |
Locked
BTIG:
Locked
➜
Locked
|
May 13 2025 |
Locked
STIFEL, FORMERLY BRYAN GARNIER:
Locked
➜
Locked
|
Apr 29 2025 |
Locked
LIFESCI CAPITAL:
Locked
➜
Locked
|
Mar 24 2025 |
Locked
ODDO BHF:
Locked
➜
Locked
|
Mar 24 2025 |
Locked
BRYAN GARNIER:
Locked
➜
Locked
|
Mar 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.